Guardado en:
Detalles Bibliográficos
Autores principales: Vershinina, Olga, Sabbatinelli, Jacopo, Bonfigli, Anna Rita, Colombaretti, Dalila, Giuliani, Angelica, Krivonosov, Mikhail, Trukhanov, Arseniy, Franceschi, Claudio, Ivanchenko, Mikhail, Olivieri, Fabiola
Formato: Preprint
Publicado: 2025
Materias:
Acceso en línea:https://arxiv.org/abs/2507.23491
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1866911230703173632
author Vershinina, Olga
Sabbatinelli, Jacopo
Bonfigli, Anna Rita
Colombaretti, Dalila
Giuliani, Angelica
Krivonosov, Mikhail
Trukhanov, Arseniy
Franceschi, Claudio
Ivanchenko, Mikhail
Olivieri, Fabiola
author_facet Vershinina, Olga
Sabbatinelli, Jacopo
Bonfigli, Anna Rita
Colombaretti, Dalila
Giuliani, Angelica
Krivonosov, Mikhail
Trukhanov, Arseniy
Franceschi, Claudio
Ivanchenko, Mikhail
Olivieri, Fabiola
contents Objective. Type 2 diabetes mellitus (T2DM) is a highly prevalent non-communicable chronic disease that substantially reduces life expectancy. Accurate estimation of all-cause mortality risk in T2DM patients is crucial for personalizing and optimizing treatment strategies. Research Design and Methods. This study analyzed a cohort of 554 patients (aged 40-87 years) with diagnosed T2DM over a maximum follow-up period of 16.8 years, during which 202 patients (36%) died. Key survival-associated features were identified, and multiple machine learning (ML) models were trained and validated to predict all-cause mortality risk. To improve model interpretability, Shapley additive explanations (SHAP) was applied to the best-performing model. Results. The extra survival trees (EST) model, incorporating ten key features, demonstrated the best predictive performance. The model achieved a C-statistic of 0.776, with the area under the receiver operating characteristic curve (AUC) values of 0.86, 0.80, 0.841, and 0.826 for 5-, 10-, 15-, and 16.8-year all-cause mortality predictions, respectively. The SHAP approach was employed to interpret the model's individual decision-making processes. Conclusions. The developed model exhibited strong predictive performance for mortality risk assessment. Its clinically interpretable outputs enable potential bedside application, improving the identification of high-risk patients and supporting timely treatment optimization.
format Preprint
id arxiv_https___arxiv_org_abs_2507_23491
institution arXiv
publishDate 2025
record_format arxiv
spellingShingle Explainable artificial intelligence model predicting the risk of all-cause mortality in patients with type 2 diabetes mellitus
Vershinina, Olga
Sabbatinelli, Jacopo
Bonfigli, Anna Rita
Colombaretti, Dalila
Giuliani, Angelica
Krivonosov, Mikhail
Trukhanov, Arseniy
Franceschi, Claudio
Ivanchenko, Mikhail
Olivieri, Fabiola
Machine Learning
Objective. Type 2 diabetes mellitus (T2DM) is a highly prevalent non-communicable chronic disease that substantially reduces life expectancy. Accurate estimation of all-cause mortality risk in T2DM patients is crucial for personalizing and optimizing treatment strategies. Research Design and Methods. This study analyzed a cohort of 554 patients (aged 40-87 years) with diagnosed T2DM over a maximum follow-up period of 16.8 years, during which 202 patients (36%) died. Key survival-associated features were identified, and multiple machine learning (ML) models were trained and validated to predict all-cause mortality risk. To improve model interpretability, Shapley additive explanations (SHAP) was applied to the best-performing model. Results. The extra survival trees (EST) model, incorporating ten key features, demonstrated the best predictive performance. The model achieved a C-statistic of 0.776, with the area under the receiver operating characteristic curve (AUC) values of 0.86, 0.80, 0.841, and 0.826 for 5-, 10-, 15-, and 16.8-year all-cause mortality predictions, respectively. The SHAP approach was employed to interpret the model's individual decision-making processes. Conclusions. The developed model exhibited strong predictive performance for mortality risk assessment. Its clinically interpretable outputs enable potential bedside application, improving the identification of high-risk patients and supporting timely treatment optimization.
title Explainable artificial intelligence model predicting the risk of all-cause mortality in patients with type 2 diabetes mellitus
topic Machine Learning
url https://arxiv.org/abs/2507.23491